Downregulation of TBK1 expression in cancer cells impaired platelet-induced EMT, which is due to the suppression of NF-κB signaling, suggesting that platelet-derived factors induce EMT in synergy with NF-κB pathways (115). This evidence concerns the gene NFKB1 and cancer.